Latest filing published 19 Jan 2011 for GT Biopharma, Inc., €27k.
Insider track record
No signal scores available.
Anshuman Dube: trading record in brief
This profile gathers the share dealings of Anshuman Dube in GT Biopharma, Inc. Over a trading history stretching from 23 December 2010 to 27 December 2010, the count stands at 3 filings.
On the market, this insider has only sold: 2 sales, €70k in total. 2011 to date brings no purchases and 2 sales.
On 19 January 2011 came the latest disclosure, a transaction for €27k in GT Biopharma, Inc. Typically, a trade is published a median of 27 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anshuman Dube
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 700,000 shares@ US$0.05Common StockSEC:0000109657-11-000008:0
- 339,900 shares@ US$0.13Common StockSEC:0000109657-11-000008:1
- 360,100 shares@ US$0.1311Common StockSEC:0000109657-11-000008:2
3 of 3 declarations